穆萨希-2通过通过破坏克鲁和斯米德1mRNA的稳定性来诱导线粒体功能障碍,导致心脏缩和心力衰竭
Sandhya Singh1, Aakash Gaur1,2, Rakesh Kumar Sharma2,3
1Pharmacology Division, CSIR-Central Drug Research Institute, Sector 10, Jankipuram Extension, Lucknow, India, 226031.
Basic research in cardiology
|November 4, 2023
概括
穆沙希-2 (Msi2) 蛋白质是基因表达的调节者,当在心脏中过度表达时会导致心脏缩,线粒体功能障碍和心力衰竭. 其下游目标Cluh和Smyd1可能具有治疗潜力.
科学领域:
- 分子生物学分子生物学
- 心血管生物学 心血管生物学
- 基因规则 基因规则
背景情况:
- RNA结合蛋白 (RBPs) 通过控制RNA稳定性和翻译来调节基因表达.
- 包括Msi1和Msi2在内的RBP的Musashi家族是已知的RNA处理的调节者.
- MSI2在心脏功能中的特定作用在很大程度上仍未被探索.
研究的目的:
- 为了研究心脏中的Musashi-2 (Msi2) 的功能.
- 确定Msi2过度表达对心脏细胞和整个心脏的影响.
- 阐明Msi2诱导的心脏病理背后的分子机制.
主要方法:
- 在心脏组织和心肌细胞中确认Msi2的存在和丰富.
- 使用RNA-seq和PCR识别Msi2异型.
- 在培养心肌细胞和体内小鼠模型中进行过度表达研究 (AAV9).
- 使用蛋白质组学,基因本体学,电子显微镜和海马试验评估心脏功能和病理学.
主要成果:
- 在心肌细胞中存在并富含Msi2,在心脏中发现了多种异型.
- 过度表达Msi2异型诱导心脏缩在体外和体内.
- 在小鼠中,Msi2的过度表达导致心脏扩张,心力衰竭和过早死亡.
- 增加的Msi2导致心脏中显著的线粒体功能障碍.
- 克鲁和Smyd1被确定为直接下游目标,可以减轻Msi2诱导的心脏功能障碍.
结论:
- Msi2在心脏中起着病理作用,诱导高,线粒体功能障碍和心力衰竭.
- Msi2对心脏的影响通过特定的异构体进行介导,并影响线粒体功能.
- 针对Msi2或其下游效应器Cluh和Smyd1,可能代表心力衰竭的治疗策略.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
15
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
15
01:29Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
01:21Myocarditis I: Introduction
9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
01:30Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
01:22Mitral Stenosis I: Introduction
15
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
01:27Heart Failure I: Introduction
14
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14